SLC25A4 Gene: Adenine Nucleotide Translocator 1 (ANT1) – Function, Mutations, and Associated Diseases
Comprehensive biomedical resource on SLC25A4 (ANT1), covering genomic context, tissue expression, pathogenic variants, and clinical significance.
Gene Information Card
| Symbol | SLC25A4 |
|---|---|
| Full Name | Solute Carrier Family 25 Member 4 |
| Gene Type | Protein coding |
| Chromosomal Location | 4q35.1 |
| NCBI Gene ID | 291 ncbi.nlm.nih.gov/gene/291 |
| Ensembl ID | ENSG00000151729 |
| UniProt ID | P12235 |
| OMIM ID | 103220 |
| HGNC ID | 10990 |
| Aliases | ANT1, PEO2, T1, AAC1, ADP/ATP translocase 1 |
Description
The SLC25A4 gene encodes the adenine nucleotide translocator 1 (ANT1), a critical inner mitochondrial membrane protein. ANT1 is the most abundant mitochondrial protein and functions as a gated pore that exchanges cytosolic ADP for mitochondrial ATP, a rate-limiting step in oxidative phosphorylation. This exchange is essential for providing energy to the cell. Mutations in SLC25A4 are primarily associated with autosomal dominant progressive external ophthalmoplegia (PEO) with mitochondrial DNA deletions and autosomal recessive mitochondrial DNA depletion syndrome (MTDPS12), which can manifest as encephalopathy, cardiomyopathy, and myopathy.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Disease | Mechanism | Evidence |
| Progressive External Ophthalmoplegia (PEO) | Dominant-negative effect of mutant ANT1 protein, leading to impaired ADP/ATP exchange, mitochondrial dysfunction, and accumulation of multiple mitochondrial DNA (mtDNA) deletions in muscle. | ClinVar, OMIM (MIM #609283) |
| Mitochondrial DNA Depletion Syndrome 12 (MTDPS12) | Recessive loss-of-function mutations causing severe reduction or absence of ANT1 protein, leading to mtDNA depletion, impaired oxidative phosphorylation, and severe multisystem disease. | ClinVar, OMIM (MIM #615418) |
| Hypertrophic Cardiomyopathy | Recessive SLC25A4 mutations can cause severe mitochondrial dysfunction in cardiac muscle, leading to hypertrophic cardiomyopathy, often in the context of MTDPS12. | ClinVar, OMIM |
| Myopathy with Exercise Intolerance | Impaired ATP production due to ANT1 deficiency leads to muscle weakness, fatigue, and exercise intolerance, often associated with mitochondrial myopathy. | ClinVar, OMIM |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Tissue | nTPM | Level |
| Skeletal Muscle | 1291.3 | High |
| Heart Muscle | 1042.7 | High |
| Liver | 82.4 | Low |
| Brain (Cerebellum) | 56.2 | Low |
| Kidney | 48.9 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| Cell Line | nTPM | Notes |
| RH-30 (Rhabdomyosarcoma) | 112.5 | High expression in muscle-derived cell line. |
| Hep G2 (Hepatocellular carcinoma) | 35.4 | Moderate expression in liver cancer cell line. |
| A-549 (Lung carcinoma) | 22.1 | Low expression in lung cancer cell line. |
| MCF-7 (Breast adenocarcinoma) | 18.7 | Low expression in breast cancer cell line. |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| Variant | Type | Frequency | Effect |
| c.239A>G (p.Asp80Gly) | Missense | Recurrent in dominant PEO | Dominant-negative effect; disrupts nucleotide translocation, leading to mtDNA multiple deletions. |
| c.702C>T (p.Arg235Cys) | Missense | Rare | Dominant-negative effect; associated with PEO and cardiomyopathy. |
| c.523C>T (p.Arg175Ter) | Nonsense | Rare | Loss-of-function; causes recessive MTDPS12 with severe phenotype. |
| c.595C>T (p.Arg199Ter) | Nonsense | Rare | Loss-of-function; causes recessive MTDPS12. |
| c.703A>G (p.Arg235His) | Missense | Rare | Dominant-negative effect; associated with PEO. |
Mutation functional classification
Loss of Function (LOF)
Recessive mutations (e.g., nonsense, frameshift) that result in a complete absence or severe truncation of the ANT1 protein. This leads to a total loss of ADP/ATP exchange activity, causing severe mitochondrial DNA depletion syndrome (MTDPS12) with early-onset encephalopathy, cardiomyopathy, and myopathy.
Gain of Function (GOF)
No clear gain-of-function mutations have been described for SLC25A4. The protein's function is strictly to exchange nucleotides, and no activating mutations are known.
Dominant Negative (DN)
Most common mechanism for autosomal dominant PEO. Missense mutations (e.g., p.Asp80Gly, p.Arg235Cys) produce a mutant protein that oligomerizes with wild-type ANT1 subunits, forming non-functional or aberrant channels. This impairs the overall ADP/ATP exchange, leading to mitochondrial dysfunction and mtDNA instability.
View complete mutation data:
Gene Ontology (GO)
| • ADP:ATP antiporter activity | • ATP:ADP antiporter activity |
| • mitochondrial inner membrane | • integral component of mitochondrial inner membrane |
| • ATP transport | • ADP transport |
| • mitochondrial transport | • oxidative phosphorylation |
| • regulation of mitochondrial membrane potential | • apoptotic process |
Pathways
• Oxidative phosphorylation (OXPHOS)
• Mitochondrial ADP/ATP transport
• Cardiac muscle contraction
• Skeletal muscle contraction
Protein Summary
The SLC25A4 protein, also known as ANT1, is a 298-amino acid protein with six transmembrane domains. It forms a homodimer in the inner mitochondrial membrane. The protein undergoes a conformational change to alternately expose its substrate binding site to the intermembrane space (for ADP) and the matrix (for ATP). This strict antiport mechanism is driven by the membrane potential and is essential for cellular energy homeostasis. The protein also plays a role in the mitochondrial permeability transition pore (mPTP), a key player in cell death pathways. Structural studies have shown that the substrate is bound in a deep cavity, and the translocation involves a rocker-switch mechanism.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SLC25A4 Knockout HEK293 Cell Line | EDJ-KQ1627 | Human | 291 | Details Get a Quote |
| SLC25A42 Knockout HEK293 Cell Line | EDJ-KQ2661 | Human | 284439 | Details Get a Quote |
| SLC25A43 Knockout HEK293 Cell Line | EDJ-KQ5532 | Human | 203427 | Details Get a Quote |
| SLC25A44 Knockout HEK293 Cell Line | EDJ-KQ6688 | Human | 9673 | Details Get a Quote |
| SLC25A46 Knockout HEK293 Cell Line | EDJ-KQ10704 | Human | 91137 | Details Get a Quote |
| SLC25A48 Knockout HEK293 Cell Line | EDJ-KQ11498 | Human | 153328 | Details Get a Quote |
| SLC25A40 Knockout HEK293 Cell Line | EDJ-KQ15314 | Human | 55972 | Details Get a Quote |
| SLC25A41 Knockout HEK293 Cell Line | EDJ-KQ15315 | Human | 284427 | Details Get a Quote |
| SLC25A47 Knockout HEK293 Cell Line | EDJ-KQ15318 | Human | 283600 | Details Get a Quote |
| SLC25A44 Knockout A-549 Cell Line | EDJ-KQ31027 | Human | 9673 | Details Get a Quote |
| SLC25A44 Knockout HCT 116 Cell Line | EDJ-KQ31028 | Human | 9673 | Details Get a Quote |
| SLC25A44 Knockout HeLa Cell Line | EDJ-KQ31029 | Human | 9673 | Details Get a Quote |
| SLC25A40 Knockout A-549 Cell Line | EDJ-KQ46021 | Human | 55972 | Details Get a Quote |
| SLC25A40 Knockout HCT 116 Cell Line | EDJ-KQ46022 | Human | 55972 | Details Get a Quote |
| SLC25A40 Knockout HeLa Cell Line | EDJ-KQ46023 | Human | 55972 | Details Get a Quote |
Displaying Records 1 To 15 Of 36 Records
- 1
- 2
- Next Page »